As one of the oncogenic transcriptional factors regulating the glycolytic phenotype of breast cancer, c-myc can drive glycolytic programming by directly up-regulating the transcription of glycolysis-related genes including GLUTs, HK2, and LDHA (Hsieh et al., 2015). This evidence concerns the gene LDHA and breast carcinoma.